🇯🇵 Florafur in Japan

PMDA authorised Florafur on 1 March 1999

Marketing authorisation

PMDA — authorised 1 March 1999

  • Marketing authorisation holder: Taiho Pharmaceutical Co, Ltd
  • Status: approved

Florafur in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Florafur approved in Japan?

Yes. PMDA authorised it on 1 March 1999.

Who is the marketing authorisation holder for Florafur in Japan?

Taiho Pharmaceutical Co, Ltd holds the Japanese marketing authorisation.